These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 561984)

  • 21. Subdermal norethindrone pellets -- a method for contraception?
    Odlind V; Moo-Young AJ; Gupta GN; Weiner E; Johansson ED
    Contraception; 1979 Jun; 19(6):639-48. PubMed ID: 487813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radioimmunoassays of ethinyl-norgestrienone (R-2323) and medroxyprogesterone acetate (MPA) and their clinical applicability.
    Frick J; Bartsch G; Jakse G
    Urol Res; 1977; 5(2):55-9. PubMed ID: 69351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogenic activity in women receiving an injectable progestogen for contraception.
    Mishell DR; Kharma KM; Thorneycroft IH; Nakamura RM
    Am J Obstet Gynecol; 1972 Jun; 113(3):372-6. PubMed ID: 4637029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion of progestogens through Silastic rubber implants.
    Lifchez AS; Scommegna A
    Fertil Steril; 1970 May; 21(5):426-30. PubMed ID: 4101385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.
    Glasier A; Thong KJ; Dewar M; Mackie M; Baird DT
    N Engl J Med; 1992 Oct; 327(15):1041-4. PubMed ID: 1522839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and endocrinologic study of continuous levonorgestrel administration from subcutaneous solid polydimethylsiloxane rods.
    Roy S; Stanczyk F; Mishell DR; Lumkin M; Gentzschein E
    Contraception; 1980 Jun; 21(6):595-615. PubMed ID: 6775868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lynestrenol 1 mg.-mestranol 0.1 mg: a new low dose oral contraceptive: a clinical study.
    Kamal I; Hefnawi F; Younis N
    Egypt Popul Fam Plann Rev; 1970 Jun; 3(1):11-5. PubMed ID: 12254506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Facilitation of receptivity in estrogen-primed rats during successive mating tests with progestins and methysergide.
    Henrik E; Gerall AA
    J Comp Physiol Psychol; 1976 Jun; 90(6):590-600. PubMed ID: 956470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menstrual regulation by sequential hormone therapy.
    Beaton JH
    West J Surg Obstet Gynecol; 1964; 72():160-3. PubMed ID: 12332438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serium protein-bound carbohydrate and seromucoid levels during long-acting progestational contraceptive therapy.
    Saleh FM
    Contraception; 1977 Oct; 16(4):399-407. PubMed ID: 923250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
    Joshi JV; Hazari KT; Shah RS; Chadha UC; Chitlange S; Gokral JS; Arolkar SG
    Steroids; 1989 Jun; 53(6):751-61. PubMed ID: 2815152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF; Mishell DR; Stanczyk FZ; Goebelsmann U
    Am J Obstet Gynecol; 1977 Sep; 129(2):133-40. PubMed ID: 900174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of action of an antifertility vaccine in the rhesus monkey: reversal of the effects of antisera to the beta-subunit of ovine luteinizing hormone by medroxyprogesterone acetate.
    Thau RB; Sundaram K
    Fertil Steril; 1980 Mar; 33(3):317-20. PubMed ID: 6767627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Concentration of estrone, estradiol and estriol in the blood of pregnant sheep after induction of estrus with chlormadinone acetate and medroxyprogesterone acetate].
    Halagan J; Arendarcik J
    Vet Med (Praha); 1976 Sep; 21(9):551-6. PubMed ID: 66795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Norethisterone contraceptive microspheres.
    Rivera R; Alvarado G; Flores C; Aldaba S; Hernandez A
    J Steroid Biochem; 1987; 27(4-6):1003-7. PubMed ID: 3695501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravaginal contraception with the synthetic progestin, R2010.
    Toivonen J
    Contraception; 1979 Nov; 20(5):511-8. PubMed ID: 527342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
    Jones GE; Wentz AC; Rosenwaks Z; Shoemaker J
    Am J Obstet Gynecol; 1977 Dec; 129(7):760-76. PubMed ID: 343592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma levels of progesterone during the luteal phase in normal women treated with synthetic oestrogens (RS 2874, F 6103 and ethinyloestradiol).
    Johansson ED; Gemzell C
    Acta Endocrinol (Copenh); 1971 Nov; 68(3):551-60. PubMed ID: 5171371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Swenson I; Khan AR; Jahan FA
    Contraception; 1980 Mar; 21(3):207-15. PubMed ID: 6446442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated intravascular coagulation induced by progesterone in the pregnant rat. Prevention by estogens.
    Stamler FW
    Am J Pathol; 1977 Mar; 86(3):603-22. PubMed ID: 65916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.